Genomics & Gene Editing
Genomics reads the genetic code and gene editing rewrites it, which can turn an inherited disease from a lifelong condition into a single treatment. Sequencing cost has fallen far enough to make study at population scale routine.
199 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
| $23.8B | +$507M | 72 | 0.99% | Increased |
|
| 2 |
BlackRock
New York
| $23.1B | -$273M | 76 | 1.06% | Reduced |
|
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
| $13.8B | -$1.15B | 41 | 2.1% | Reduced |
|
| 4 |
Fidelity Investments
Boston,
Massachusetts
| $12.5B | -$920M | 45 | 1.44% | Reduced |
|
| 5 |
State Street
Boston,
Massachusetts
| $11.5B | -$202M | 63 | 0.96% | Reduced |
|
| 6 |
Capital Research Global Investors
Los Angeles,
California
| $10.1B | +$228M | 9 | 2.77% | Increased |
|
| 7 |
Wellington Management Group
Boston,
Massachusetts
| $9.23B | +$476M | 30 | 2.06% | Increased |
|
| 8 |
Massachusetts Financial Services
Boston,
Massachusetts
| $7.49B | -$234M | 10 | 3.21% | Reduced |
|
| 9 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
| $7.07B | -$160M | 8 | 7.63% | Reduced |
|
| 10 |
Capital World Investors
Los Angeles,
California
| $6.21B | +$490M | 14 | 1.33% | Increased |
|
| 11 |
Morgan Stanley
New York
| $4.55B | +$97.4M | 81 | 1.23% | Increased |
|
| 12 |
Dodge & Cox
San Francisco,
California
| $4.28B | -$44.6M | 4 | 3.42% | Reduced |
|
| 13 |
Primecap Management
Pasadena,
California
| $4.27B | -$181M | 11 | 3.17% | Reduced |
|
| 14 |
Bank of America
Charlotte,
North Carolina
| $4.03B | +$179M | 74 | 0.67% | Increased |
|
| 15 |
Northern Trust
Chicago,
Illinois
| $3.83B | -$73.6M | 68 | 0.97% | Reduced |
|
| 16 |
Geode Capital Management
Boston,
Massachusetts
| $3.41B | +$124M | 74 | 1.05% | Increased |
|
| 17 |
Franklin Resources
San Mateo,
California
| $3.33B | -$9.85M | 18 | 1.71% | Reduced |
|
| 18 |
Norges Bank
Oslo,
Norway
| $2.95B | +$1.17M | 22 | 1.01% | Increased |
|
| 19 |
Goldman Sachs
New York
| $2.72B | -$385M | 59 | 0.74% | Reduced |
|
| 20 |
Bank of New York Mellon
New York
| $2.65B | -$163M | 65 | 0.72% | Reduced |
|
| 21 |
Invesco
Atlanta,
Georgia
| $2.6B | +$573M | 38 | 0.86% | Increased |
|
| 22 |
Wells Fargo
San Francisco,
California
| $2.5B | +$117M | 72 | 0.74% | Increased |
|
| 23 |
JP Morgan Chase
New York
| $2.21B | -$86.4M | 61 | 0.45% | Reduced |
|
| 24 |
Janus Henderson Group
London,
| $2.18B | +$71.6M | 16 | 1.24% | Increased |
|
| 25 |
Sands Capital Management
Arlington,
Virginia
| $2.16B | -$84.6M | 3 | 6.18% | Reduced |
|